Stratakis C A, Jenkins R B, Pras E, Mitsiadis C S, Raff S B, Stalboerger P G, Tsigos C, Carney J A, Chrousos G P
Section on Pediatric Endocrinology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892-1862, USA.
J Clin Endocrinol Metab. 1996 Oct;81(10):3607-14. doi: 10.1210/jcem.81.10.8855810.
Carney complex (CC) is a familial multiple neoplasia and lentiginosis syndrome, transmitted in an autosomal dominant manner. It is the only familial form of cardiac and skin myxomas known and includes endocrine neoplasms causing Cushing's syndrome [primary pigmented nodular adrenocortical disease (PPNAD)] and acromegaly (GH-producing adenoma). The molecular defect leading to CC remains unknown, but was recently mapped to chromosome 2p16 by linkage analysis. This region has exhibited cytogenetic aberrations in atrial myxomas from patients with CC and harbors the hMSH2 and hMSH6 genes, which are involved in the preservation of microsatellite length stability of replicating human cells. In the present study, we examined 15 tumor and normal tissue specimens from 13 patients with CC [GH-producing adenoma (n = 1), adrenal tumors (PPNAD, n = 8), thyroid cancer (n = 1), normal adrenal gland (n = 1)] and 4 cultured cell lines [heart myxoma (n = 3) and eyelid myxoma (n = 1)]. Chromosome analysis was obtained by standard cytogenetic techniques. One of the myxoma cell lines and 3 PPNAD specimens contained multiple telomeric associations (tas). The normal adrenocortical tissue from a patient with PPNAD contained no apparent chromosomal anomalies, whereas the neighboring PPNAD tissue demonstrated tas. DNA was extracted from peripheral blood, tumor cell lines, and frozen or paraffin-embedded tissues and subjected to PCR amplification with primers from 64 microsatellite locations covering chromosomes 1 and 3-22 and 14 loci covering chromosome 2. The alterations detected were loss and gain of heterozygosity (LOH and GOH; 49% and 26%, respectively), deletions of both alleles (DEL; 10%), and microsatellite length instability (15%). GOH and LOH were the most frequent changes, with telomeric markers significantly over-represented (P < 0.05). Chromosomes 6, 11, 22, 10, and 19 demonstrated mostly LOH, GOH, or DEL in over 40% of the informative loci tested (73%, 59%, 47%, 46%, and 44%, respectively), whereas markers on chromosome 2 showed only microsatellite length instability (10%). The degree of genomic instability and its type were independent of tumor type (P > 0.1). We conclude that tumors and tumor cell lines from patients with CC demonstrate significant genomic, but not microsatellite length, instability. Thus, the CC gene(s) on chromosome 2p16 is different from the hMSH2 and hMSH6 genes and has dominant, rather than recessive, tumorigenic function. This gene(s) appears to be involved in the regulation of genomic stability of dividing cells, in particular the structure of telomeres in replicating chromosomes and/or the function of the mitotic apparatus.
卡尼综合征(CC)是一种以常染色体显性方式遗传的家族性多发性肿瘤和雀斑综合征。它是已知的唯一一种家族性心脏和皮肤黏液瘤形式,包括导致库欣综合征的内分泌肿瘤[原发性色素沉着性结节性肾上腺皮质病(PPNAD)]和肢端肥大症(生长激素分泌性腺瘤)。导致CC的分子缺陷尚不清楚,但最近通过连锁分析将其定位到2号染色体p16区域。该区域在CC患者的心房黏液瘤中表现出细胞遗传学异常,并含有hMSH2和hMSH6基因,这两个基因参与维持人类复制细胞的微卫星长度稳定性。在本研究中,我们检测了13例CC患者的15个肿瘤和正常组织标本[生长激素分泌性腺瘤(n = 1)、肾上腺肿瘤(PPNAD,n = 8)、甲状腺癌(n = 1)、正常肾上腺(n = 1)]以及4种培养细胞系[心脏黏液瘤(n = 3)和眼睑黏液瘤(n = 1)]。通过标准细胞遗传学技术进行染色体分析。其中一个黏液瘤细胞系和3个PPNAD标本含有多个端粒联合(tas)。一名PPNAD患者的正常肾上腺皮质组织未发现明显的染色体异常,而相邻的PPNAD组织则显示有tas。从外周血、肿瘤细胞系以及冷冻或石蜡包埋组织中提取DNA,并使用覆盖1号染色体和3 - 22号染色体的64个微卫星位点的引物以及覆盖2号染色体的14个位点的引物进行PCR扩增。检测到的改变包括杂合性缺失和增加(分别为LOH和GOH;分别为49%和26%)、两个等位基因的缺失(DEL;10%)以及微卫星长度不稳定性(15%)。GOH和LOH是最常见的变化,端粒标记显著过量(P < 0.05)。在超过40%的检测信息位点中,6号、11号、22号、10号和19号染色体大多显示LOH、GOH或DEL(分别为73%、59%、47%、46%和44%),而2号染色体上的标记仅显示微卫星长度不稳定性(10%)。基因组不稳定性的程度及其类型与肿瘤类型无关(P > 0.1)。我们得出结论,CC患者的肿瘤和肿瘤细胞系表现出显著的基因组不稳定性,但不是微卫星长度不稳定性。因此,2号染色体p16上的CC基因不同于hMSH2和hMSH6基因,具有显性而非隐性的致瘤功能。该基因似乎参与了分裂细胞基因组稳定性的调节,特别是复制染色体中端粒的结构和/或有丝分裂装置的功能。